COVID-19 vaccines focus on the spike protein – but here's another target
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
Dec 10, 2020
0
18
